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Abstract: Phenolic compounds present in our diet play an important role in colon cancer chemoprevention. Previous results
demonstrated that peanut testa extract inhibited both histone deacetylase (HDAC) activity and the growth of colon cancer cells. In
this study, four identified phenolic compounds in peanut testae (resveratrol, p-coumaric acid, ferulic acid, and sinapinic acid) were
investigated for their HDAC inhibitory and anticancer activities against colon cancer cell lines. In vitro study revealed that resveratrol
exhibited the greatest HDAC inhibitory activity. Molecular docking studies demonstrated that all four compounds could bind both
HDAC1 and HDAC2. Resveratrol exhibited the most effective antiproliferative activity against both human colon adenocarcinoma
(HT29) and human colorectal carcinoma (HCT116) cells. Apoptosis induction by ferulic acid and resveratrol appeared to be associated
with p53 activation in HCT116 cells. However, resveratrol, p-coumaric acid, ferulic acid, and sinapinic acid induced apoptosis of HT29
cells in a p53-independent manner. Low-concentration treatments of p-coumaric and ferulic acids resulted in cell cycle arrest of HCT116
cells. In contrast, high-concentration treatments of p-coumaric and ferulic acids showed cell death activation as evidenced by increased
sub-G1 fractions. The induction of p21 by p-coumaric acid and resveratrol correlated well with the decreased CDK4 levels and cell cycle
arrest. Resveratrol, p-coumaric acid, ferulic acid, and sinapinic acid caused activation of pERK1/2 in HCT116 cells, whereas ferulic and
sinapinic acids caused downregulation of pERK1/2 in HT29 cells. These results suggest that these peanut phenolics may be potential
antineoplastic agents for colon cancer chemoprevention/chemotherapy.
Key words: HDAC inhibitor, peanut (Arachis hypogaea L.), p-coumaric acid, ferulic acid, sinapinic acid, resveratrol

1. Introduction
Colon cancer, one of the most common cancers in
developed countries, is closely linked with dietary and
lifestyle practices (Jemal et al., 2010). Dietary intake of
plant-derived phenolic-rich ingredients might be a good
and feasible strategy for preventing and controlling the
incidence of colorectal cancer (Center et al., 2009). Phenolic
compounds are the most abundant antioxidants among the
bioactive phytochemicals present in our diet (Edwards et
al., 2010), serving as natural cancer chemopreventive agents
(Link et al., 2010). Generally, the underlying mechanisms
for their anticancer effects include antioxidation,
antiproliferation, and the activation and/or inhibition of
some subcellular signaling pathways, namely apoptosis and
cell cycle progression (Yang et al., 2001). Among plantbased diets, peanut seeds (Arachis hypogaea L) are popularly
consumed worldwide and the peanut testa has been found
to contain several types of phenolic compounds, including
resveratrol, p-coumaric acid, ferulic acid, and sinapinic acid
* Correspondence: sthanaset@kku.ac.th
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(Udenigwe et al., 2008; Khaopha et al., 2012). Peanut testae
have been shown to possess potent antioxidant, anticancer,
and antiinflammatory activities (Chang et al., 2006). We
have previously demonstrated that phenolic-rich extracts
of peanut testae exhibited histone deacetylase (HDAC)
inhibitory and anticancer activities in several human
cancer cells (Khaopha et al., 2015). However, the types of
phenolic compounds conferring HDAC inhibitory and
anticancer properties to peanut testa extracts remains to
be investigated. Our previous study (Khaopha et al., 2015)
demonstrated that peanut testa extracts possessing HDAC
inhibitory activity could inhibit the growth of human
colon adenocarcinoma (HT29) cells and human colorectal
carcinoma (HCT116) cells. However, the cytotoxic effects of
the phenolics found in peanut testa extracts on colon cancer
cell lines HT29 (p53-mutant) and HCT116 (p53-wild type)
have not yet been explored.
HDAC inhibitors have been shown to cause
transcriptional activation of a few silenced tumor
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suppressor genes by reversible epigenetic changes (Marks
et al., 2000; Kim et al., 2013). At present, there remains a
continuous need for exploring new HDAC inhibitors with
improved pharmacological efficacy and unique modes of
action. The loss of protein expression involved in growth
inhibition and induction of apoptosis is one of the most
common reasons for uncontrolled growth of cancer cells
(Roberts et al., 2002). Tumor suppressor protein p53 plays
a key role in preventing tumor cell growth (Banin et al.,
1998), whereas cyclins and cyclin-dependent kinases
(CDKs) regulate cell cycle progression. The induction
of p21, a CDK inhibitor, is responsible for arresting cell
cycle progression via p53-dependent and -independent
pathways (Gartel, 2005). Decreased CDK4 expression and
increased p21WAF1 expression were associated with cell cycle
arrest (Cho et al., 2001; Sherr et al., 2002). Moreover, a
mitogen-activated protein kinase (MAPK) or extracellular
signal-regulated kinase 1/2 (ERK1/2) signaling cascade
is of great importance in regulating various cellular
responses, including proliferation, differentiation, survival,
and cell death. The cascade is activated through receptormediated signaling stimuli (Mordret, 1993). The ERK
signaling is synonymous with cell proliferation and found
to be deregulated in about one-third of all human cancers
(Dhillon et al., 2007). In the ERK/MAPK model, ERK1/2
is activated upon phosphorylation by MEK1/2, which is
itself activated when phosphorylated by Raf (Johnson
et al., 1996). Cell death could be induced through ERK
activation by the generation of reactive oxygen species
(ROS) and endoplasmic reticulum stress predominantly
via the PERK-eIF2α pathway (Arai et al., 2004). However,
the mechanisms used by peanut phenolic compounds to
inhibit cancer cell growth remain to be explored.
The investigation of HDAC inhibitory activity of
phenolic compounds found in peanut seeds may lead to
the discovery of safe and potentially chemopreventive
natural agents. To validate that peanuts are a natural
source of HDAC inhibitors, the HDAC inhibitory activity
of peanut phenolic compounds, including resveratrol,
p-coumaric acid, ferulic acid, and sinapinic acid, was
demonstrated both in vitro and in cancer cell lines. The
effects of these phenolic compounds on the proliferation,
apoptosis, and cell cycle progression of colon cancer cells
were demonstrated. In addition, the levels of p21, CDK4,
p53, and pERK1/2 upon treatment with these phenolic
compounds were also investigated.
2. Materials and methods
2.1. Materials
Propidium iodide, sodium butyrate (purity ≥98.5%),
resveratrol (purity ≥99.0%), p-coumaric acid (purity
≥98.8%), ferulic acid (purity ≥99.0%), and sinapinic acid
(purity ≥98.0%) were purchased from Sigma-Aldrich.

Antibodies against H3, p21, CDK4, β-actin, pERK1/2,
and ERK1/2 proteins were purchased from Cell Signaling
Technology. Anti-p53 antibody was purchased from Santa
Cruz Biotechnology. The Vybrant Apoptosis Assay Kit
#2 and MTT were purchased from Molecular Probes,
Invitrogen.
2.2. Cell culture
The colon cancer cell lines (HT29 and HCT116) and
noncancer cell lines (Vero) used in this study were
maintained in RPMI-1640 medium supplemented with
10% fetal bovine serum, penicillin (100 U/mL), and
streptomycin (100 µg/mL) (GIBCO-BRL). The cells were
incubated in a humidified incubator with an atmosphere
of 5% CO2 at 37 °C.
2.3. In vitro HDAC inhibitory activity
In vitro HDAC inhibitory activity was determined
using the Fluor-de-Lys HDAC Fluorometric Activity
Assay Kit (Biomol). Four peanut phenolics, resveratrol,
p-coumaric acid, ferulic acid, and sinapinic acid, at various
concentrations, were assessed for their HDAC inhibitory
activity against the mixture of HDAC enzymes from the
HeLa nuclear extract provided with the kit. The assay was
performed according to the manufacturer’s instructions.
Fluorescence was measured using a Spectra Max Gemini
XPS microplate spectrofluorometer (Molecular Devices)
with excitation at 360 nm and emission at 460 nm.
2.4. In silico molecular docking studies
AutoDock tools were used to analyze the binding energy
(ΔG) and inhibitory constant (Ki). The Molecular Graphics
Laboratory tools and AutoDock 4.2 were downloaded
from www.scripps.edu. Cygwin (for data storage) and
Discovery Studio Visualizer 4.0 were downloaded from
www.cygwin.com and www.accelerys.com, respectively.
The chemical structure of the phenolic compounds was
drawn in the form of a chemical diagram using Spartan
Student 4.1.1. The human HDAC1 and HDAC2 crystal
structures were collected from a databank (http://www.
rcsb.org/pdb/staticHelp.do?p=help/ligandSearch.html).
For each ligand, the 10 best positions were generated and
scored using the AutoDock 4.2 scoring functions according
to methods previously described (Park et al., 2006). The
conformations with the best docking, as determined from
the clustering histogram, were those with low binding
energy. Binding energy is a measure of the affinity of a
ligand–protein complex, or the difference between the
energy of the complex and the sum of the energies of each
molecule separately. The binding energy of the individual
compound was calculated using the following formula:
binding energy = A + B + C – D,
where A denotes the final intermolecular energy + Van der
Waals energy + hydrogen bonds + desolvation energy +
electrostatic energy (kcal/mol), B denotes the final total
internal energy (kcal/mol), C denotes the torsional free
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energy (kcal/mol), and D denotes the unbound system
energy (kcal/mol). The inhibitory constant (Ki) is the
concentration of the inhibitor required to produce half of
the maximum inhibition.
2.5. Cell growth inhibition
Cell growth inhibition was measured by MTT assay.
Briefly, colon cancer (HT29 and HCT116) and noncancer
(Vero) cell lines were seeded in 96-well plates at a density
of 8 × 103 cells per well for 24 h. Cells were treated with
resveratrol (0–200 µM), p-coumaric acid (0–3 mM),
ferulic acid (0–3 mM), sinapinic acid (0–3 mM), and NaB
(0–6 mM) and incubated for 24, 48, and 72 h. Dimethyl
sulfoxide (DMSO) was used at 0.5% as the vehicle control.
The culture medium was then replaced with fresh medium
containing 1.2 mM MTT and incubated for 2 h at 37 °C.
After 2 h of incubation, formazan produced in the culture
cells was dissolved with DMSO, and the absorbance at 550
nm was measured with a microtiter plate reader (Bio-Rad
Laboratories) using 655 nm as a reference wavelength.
2.6. Apoptosis analysis by flow cytometry
Induction of apoptosis was assayed using the Vybrant
Apoptosis Assay Kit #2 (Molecular Probes, Invitrogen)
according to the manufacturer’s instructions with a BD
FACSCanto II flow cytometer (Becton Dickinson). To
start, cells (~1 × 106) were seeded into a 5.5-cm dish and
incubated for 24 h. The cells were then treated with three
different concentrations of resveratrol (50, 100, and 150
µM), p-coumaric acid (1, 2.5, and 5 mM), ferulic acid (1,
2.5, and 5 mM), and sinapinic acid (1, 2.5, and 5 mM) or
solvent (DMSO, 0.37%) for 24 h. After incubation, the
treated cells were harvested, centrifuged, and washed
twice with ice-cold PBS. Cells were suspended in 100 µL
ice-cold annexin-binding buffer and stained with Alexa
Fluor 488-annexin V and propidium iodide (PI) solutions.
The samples were then kept in the dark for 15 min at room
temperature and analyzed by flow cytometry.
2.7. Cell cycle analysis by flow cytometry
Cell cycle phase distribution was evaluated using a method
as previously described by Poolman and Brooks (1998).
Cells were seeded into a 5.5-cm dish (~1 × 106 cells/
dish), incubated for 24 h, and treated with three different
concentrations of resveratrol (50, 100, and 150 µM),
p-coumaric acid (1, 2.5, and 5 mM), ferulic acid (1, 2.5, and
5 mM), and sinapinic acid (1, 2.5, and 5 mM) or solvent
(DMSO, 0.37%) for 24 h. The cells were then harvested,
centrifuged, and fixed in ice-cold 70% ethanol. The fixed
cells were again centrifuged and resuspended in 300 µL
of PBS. The cells were incubated with RNase A (final
concentration of 0.2 mg/mL) at 37 °C for 1 h and stained
with a propidium iodide solution (final concentration of 50
µg/mL) at room temperature for 45 min. The labeled cells
were analyzed using a BD FACSCanto II flow cytometer
(Becton Dickinson).
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2.8. Western blot analysis
Levels of the proteins of interest were detected by western
blot following the established method. The total cellular
proteins were prepared from drug-treated and solventtreated cells using RIPA lysis buffer. Equal amounts of
protein (30 µg) were separated by 10%–12.5% SDS-PAGE
and transferred to a polyvinylidene fluoride (PVDF)
membrane. The membrane was then blocked with 5%
skim milk for 1 h and subsequently incubated overnight
with a primary antibody: anti-p21, antiacetylated H3,
anti-CDK4, anti-pERK1/2, anti-ERK1/2, anti-p53, or antiβ-actin. The proteins were then probed with a horseradish
peroxidase-conjugated secondary antibody at room
temperature. Protein bands were visualized using ECL
prime chemiluminescence (Amersham).
2.9 Statistical analysis
Data are expressed as the mean ± standard deviation (SD)
from three independent experiments. Duncan’s post hoc
test was carried out using SPSS 20.0 (IBM Corporation).
Significant differences (P < 0.05) among phenolic
compounds were analyzed using one-way analysis of
variance.
3. Results
3.1. HDAC inhibitory activity of four peanut phenolic
compounds
The HDAC inhibitory activity of four peanut phenolic
compounds (Udenigwe et al., 2008; Khaopha et al., 2012)
was investigated both in vitro and in silico in comparison
with a well-known HDAC inhibitor, sodium butyrate
(NaB). As shown in Table 1, all four phenolic compounds
could inhibit HDAC activity in vitro and resveratrol had
the lowest IC50 value (0.4 ± 0.05 mM) against the crude
HDAC enzymes from the HeLa nuclear extract, followed
by ferulic acid (1.9 ± 0.1 mM), sinapinic acid (2.3 ± 0.1
mM), and p-coumaric acid (2.6 ± 0.1 mM). Compared to
the IC50 value of NaB (1.02 ± 0.1 mM), only resveratrol
possessed more potent HDAC inhibitory activity than NaB
in vitro. To support the in vitro results, an in silico study or
molecular docking was conducted using these compounds
as ligand molecules docking with crystal structures of
both human HDAC1 and HDAC2, the two major HDAC
family members found in most transcriptional repression
complexes (Hassig et al., 1998). The results revealed that
all of the inhibitor compounds bind with one or more
amino acids in the active pockets of the enzymes (data
not shown). The calculated binding energy (ΔG) and
inhibitory constant (Ki) of the individual compounds
are shown in Table 1. Theoretically, all four phenolic
compounds showed very good binding energy compared
to that of the well-known HDAC inhibitor NaB. According
to the binding energy and inhibitory constant, all four
phenolic compounds (ΔG = –3.4 to –4.9 kcal/mol, Ki =
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Table 1. Half maximal inhibitory concentrations (IC50) of phenolic compounds after exposure to HDAC enzymes in vitro and their
binding energy and inhibitory constants against HDAC1 and HDAC2 in silico.
In vitro

In silico

HDACsa

HDAC1

IC50 valuesb
(mM)

Binding
energy (ΔG)
(kcal/mol)

Inhibitory
constant
(Ki)

Binding
energy (ΔG)
(kcal/mol)

Inhibitory
constant
(Ki)

p-Coumaric acid

2.6 ± 0.1

–3.5

2.9 mM

–5.1

170.8 µM

Ferulic acid

1.9 ± 0.1

–4.3

673.3 µM

–4.6

451.8 µM

Sinapinic acid

2.3 ± 0.1

–3.4

3.3 mM

–3.9

1.5 mM

Resveratrol

0.4 ± 0.1

–4.9

271.6 µM

–4.8

328.7 µM

Sodium butyratec

1.0 ± 0.1

–2.9

8.0 mM

–4.7

375.3 µM

Compounds

Chemical structure

HDAC2

The mixture of HDAC enzymes in the HeLa nuclear extract.
IC50 values are shown as mean ± SD from three independent experiments, representing the concentrations of the indicated compounds
that inhibit 50% of HDAC activity.
c
A well-known HDAC inhibitor.
a

b

0.3 to 3.3 mM) appeared to interact with HDAC1 more
efficiently than NaB (ΔG = –2.9 kcal/mol, Ki = 8.0 mM). In
contrast, only p-coumaric acid (ΔG = –5.1 kcal/mol, Ki =
170.8 mM) showed a better interaction with HDAC2 than
NaB (ΔG = –4.7 kcal/mol, Ki = 375.3 µM). These results
indicate that all four phenolic compounds found in peanut
testa extracts (Khaopha et al., 2015) function as HDAC
inhibitors capable of inhibiting HDAC enzymes.
3.2. Antiproliferative activity of four peanut phenolic
compounds
To determine the antiproliferative activity of these
compounds, the MTT assay was used to evaluate their
growth inhibition activity against human colon cancer
cell lines HT29 and HCT116 and noncancer (Vero) cells.
A dose-response curve showed that all four phenolic
compounds inhibited the proliferation of colon cancer cell
lines in a time-dependent and dose-dependent manner
(data not shown). Cellular sensitivity was determined
by calculating the IC50 against each compound (Table 2).
Resveratrol produced a more profound cytotoxic effect
in colon cancer cells. Consistent with our previous report
(Senawong et al., 2014), p-coumaric, ferulic, and sinapinic

acids exhibited similar IC50 values against HT29, HCT116,
and Vero cells at 72 h of exposure. In line with our findings,
previous reports documented the growth inhibition effects
of plant phenolics on colon cancer cells (Yi et al., 2005).
In addition, p-coumaric, ferulic, and sinapinic acids were
more cytotoxic than NaB. However, it has been reported
that sinapinic acid inhibited the growth of HeLa and Jurkat
cells less effectively than sodium butyrate (Senawong et al.,
2013).
3.3. Hyperacetylation of histone H3 by peanut phenolic
compounds in colon cancer cells
As presented above, we observed that all four phenolic
compounds possessed in vitro HDAC inhibitory activity
and inhibited the growth of both colon cancer cell lines.
Therefore, we aimed to explore the HDAC inhibitory
activity of these compounds in both cancer cell lines by
determining the acetylation status of histone H3 using
western blot analysis. As demonstrated in Figure 1, all
four phenolic compounds, p-coumaric acid (Figures 1A
and 1B), ferulic acid (Figures 1C and 1D), sinapinic acid
(Figures 1E and 1F), and resveratrol (Figures 1G and 1H),
caused hyperacetylation of histone H3 in both HT29 and
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Table 2. Antiproliferative activity of the four phenolic compounds represented by IC50 values after exposures to colon cancer cell lines
for 24, 48, and 72 h.
IC50 valuesa
Phenolic compounds

HT29 cells

HCT116 cells

Vero cellsb

24 h

48 h

72 h

24 h

48 h

72 h

24 h

48 h

72 h

p-Coumaric acid (mM)

>3

1.3 ± 0.2

1.0 ± 0.2

>3

2.4 ± 0.3

1.3 ± 0.8

>3

>3

2.9 ± 0.7

Ferulic acid (mM)

>3

2.4 ± 0.1

2.2 ± 0.2

>3

2.5 ± 0.9

2.1 ± 0.4

>3

>3

2.8 ± 0.6

Sinapinic acid (mM)

>3

2.7 ± 0.3

2.6 ± 0.4

>3

3.0 ± 0.5

2.7 ± 0.1

>3

>3

>3

Resveratrol (µM)

>200

131.2 ± 9.8

99.8 ± 8.7

190.3 ± 1.2

129.6 ± 6.3

99.8 ± 12.2

>200

193.4 ± 8.8

166.3 ± 0.8

Sodium butyrate (mM)

>6

5.4 ± 0.7

3.7 ± 0.2

>6

4.5 ± 0.7

3.8 ± 0.3

>6

5.0 ± 0.5

4.1 ± 0.5

c

IC50 values or half maximal inhibitory concentrations are shown as means ± SD from three independent experiments.
Noncancer cell line.
c
A well-known HDAC inhibitor.
a

b

HCT116 cells, indicating that all four compounds could
inhibit HDAC activity in a cellular context compared with
the HDAC inhibitor NaB (Figures 1I and 1J). Among the
four compounds, resveratrol was shown to possess the most
potent HDAC inhibitory activity in both HT29 (Figure
1G) and HCT116 (Figure 1H) cells, which correlates well
with its activity in vitro (Table 1).
3.4 Peanut phenolic compounds induce apoptosis in
human colon cancer cell lines
To elucidate the mechanism underlying cell growth
inhibition by the peanut phenolic compounds, induction
of apoptosis in colon cancer cell lines was examined. As
shown in Figure 2, all four phenolic compounds exhibited
a significant effect on induction of apoptosis in both HT29
and HCT116 cells. In the HT29 cells, treatments with
increasing concentrations of p-coumaric acid (Figure
2A), ferulic acid (Figure 2B), sinapinic acid (Figure 2C),
resveratrol (Figure 2D), and NaB (Figure 2E) increased
the percentage of apoptotic cells. Similarly, the percentage
of HCT116 apoptotic cells also increased after treatment
with these phenolic compounds (Figures 2F–2I) and
NaB (Figure 2J). In addition, the percentage of apoptotic
noncancer cells was lower than that of apoptotic cancerous
cells, indicating that the peanut phenolic compounds
(Figures 2K–2N) were less toxic to a noncancer cell line
than to cancerous cell lines. In contrast, NaB exhibited
more toxicity to a noncancer cell line (Figure 2O) than to
cancerous cell lines (Figures 2E and 2J).
3.5. Peanut phenolic compounds induce cell cycle arrest
in human colon cancer cell lines
Cell cycle arrest was further examined by flow cytometry
after treatment with the phenolic compounds. As presented
in Table 3, the HT29 cells showed a significant increase
in the number of sub-G1 cells along with concomitant
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decrease of the G0/G1 population when treated with
resveratrol, p-coumaric acid, ferulic acid, and sinapinic
acid. NaB caused an increase of cells in the S phase but
a decrease in the G2/M phase. In contrast, the HCT116
cells were arrested in the G0/G1 phase after treatment with
p-coumaric acid, ferulic acid, and sinapinic acid, whereas
an S phase arrest was observed with the resveratrol
treatment. Of note, the NaB-treated HCT116 cells showed
a prominent sub-G1 fraction.
3.6. Peanut phenolic compounds induced inhibition of
ERK1/2 pathway
The effects of the phenolic compounds on the MAPK (ERK)
signaling pathway of colon cancer cells were investigated
by western blot analysis. p-Coumaric acid caused an
increase in the level of pERK1/2 in both the HT29 (Figure
3A) and the HCT116 (Figure 3B) cells. In contrast, ferulic
acid caused an inhibition of the MAPK signaling pathway
in the HT29 cells (Figure 3C), but activated the MAPK
signaling pathway in the HCT116 cells (Figure 3D).
Similarly, sinapinic acid decreased the pERK1/2 level in the
HT29 cells (Figure 3E), but increased the pERK1/2 level in
the HCT116 cells (Figure 3F). Resveratrol increased the
level of pERK1/2 at all concentrations tested in the HT29
cells (Figure 3G), and at the highest concentration (200
µM) in the HCT116 cells (Figure 3H). Furthermore, the
NaB treatments caused a reduction of pERK1/2 in both
the HT29 (Figure 3I) and the HCT116 (Figure 3J) cells,
especially at high concentration treatments.
3.7. Western blot analysis of cell cycle and apoptosis
regulatory proteins
To explore the molecular mechanisms underlying growth
inhibition of colon cancer cells, HT29 (p53-mutant) and
HCT116 (p53-wild type), by peanut phenolic compounds,
the expression of some cell cycle and apoptosis regulatory
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HCT116

HT29
B

A
Ac-H3
(fold increase)

3
2
1
0

C

1.0 2.5 5.0

Ac-H3
(fold increase)

Ac-H3
-actin

Ac-H3
-actin

3
2
1
0

C

p-Coumaric acid (mM)

p-Coumaric acid (mM)

Ac-H3
-actin
2

1.0 2.5 5.0

Ac-H3
(fold increase)

D

Ac-H3
(fold increase)

C
Ac-H3
-actin
3
2
1
0

C

1
0

C

F

0

C

1.0 2.5 5.0
Sinapinic acid (mM)

G

C

1.0 2.5 5.0
Sinapinic acid (mM)

H
Ac-H3
-actin

Ac-H3
-actin
Ac-H3
(fold increase)

Ac-H3
(fold increase)

1

Ac-H3
-actin
3
2
1
0

2
1
0

C

50 100 150

Ac-H3
(fold increase)

Ac-H3
(fold increase)

Ac-H3
-actin
2

3
2
1
0

C

Resveratrol (μM)

50 100 150
Resveratrol (μM)

J

I
-actin

-actin
6
4
2
0

4
3
2
1
0

C

1.0 2.5 5.0
NaB (mM)

Ac-H3
(fold increase)

Ac-H3

Ac-H3

Ac-H3
(fold increase)

1.0 2.5 5.0
Ferulic acid (mM)

Ferulic acid (mM)

E

1.0 2.5 5.0

C

1.0 2.5 5.0
NaB (mM)

Figure 1. Hyperacetylation of histone H3 by peanut phenolic compounds and NaB. Acetylated histone-H3 levels increased in HT29 (A,
C, E, G, and I) and HCT116 (B, D, F, H, and J) cells after exposure to varying concentrations of phenolic compounds for 24 h. The control
(C) represents the level of acetylated (Ac)-H3 in the solvent control treatment. β-actin was used as a loading control. Quantification of
the relative expression of Ac-H3 in HT29 and HCT116 cells was determined using Genetool software (Genesys).
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Figure 2. The effect of peanut phenolic compounds on apoptosis induction. HT29, HCT116, and noncancer (Vero) cells were incubated for 24 h with p-coumaric acid (A, F, and
K), ferulic acid (B, G, and L), sinapinic acid (C, H, and M), resveratrol (D, I, and N), and the well-known HDAC inhibitor NaB (E, J, and O). S and P represent solvent (DMSO) and
camptothecin treatments, respectively. *: Significant difference between solvent control and treatment (P < 0.05).
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Figure 3. The effect of peanut phenolic compounds on ERK1/2 activation. HT29 and HCT116 cells were exposed to 0.37% DMSO
(solvent control) and varied concentrations of p-coumaric acid (A and B), ferulic acid (C and D), sinapinic acid (E and F), resveratrol
(G and H), and NaB (I and J) for 4 h. Serum-starved HT29 and HCT116 cells were stimulated with 750 ng/mL EGF for 1 h after 3
h of preincubation with or without phenolic compounds. Total ERK1/2 was used as a loading control. Quantification of the relative
expression of pERK1/2 in HT29 and HCT116 cells was determined using Genetool software (Genesys).

1266

SAENGLEE et al. / Turk J Biol
proteins were evaluated by western blotting. In this study,
three proteins related to cell growth inhibition (p21,
CDK4, and p53) were investigated. p21 is one of the p53regulated protein targets of HDAC inhibitor-mediated
suppression to control cell cycle progression. In the HT29
cells, p-coumaric acid (Figure 4A) induced p21 expression,
whereas ferulic (Figure 4B) and sinapinic (Figure 4C)
acids decreased p21 level. Resveratrol (Figure 4D) and
NaB (Figure 4E) also increased the p21 level compared to
the solvent control treatment (Figure 4F). CDK4, a protein
associated with cell cycle regulation, was also detected in
the same condition. In the HT29 cells, all of the phenolic
compounds and NaB caused a downregulation of CDK4
(Figure 4G). Mutant p53 protein expression was constant
for the phenolic compounds and NaB treatments (Figure
4H) in the HT29 cells.
In HCT116 cells, p21 expression was increased when
treated with p-coumaric acid (Figure 4I), but it decreased
when cells were treated with ferulic (Figure 4J) and sinapinic
(Figure 4K) acids. Furthermore, resveratrol (Figure 4L) at
a concentration of 150 µM caused a decrease of p21 in the
HCT116 cells. The increase of p21 upon treatments with
p-coumaric acid and NaB (Figure 4M) appeared to be
independent of p53 in the HCT116 cells (Figure 4N). All
four phenolic compounds and NaB caused a reduction in
CDK4 expression in the HCT116 cells (Figure 4O). In the
HCT116 cells, the expression of p53 remained unaltered
after the p-coumaric acid and sinapinic acid treatments,
but it was upregulated when treated with ferulic acid and
resveratrol (Figure 4P). However, the p53 level seemed to
decrease after NaB treatment (Figure 4P). Interestingly, the
resveratrol-treated HCT116 cells exhibited an increased
p53 level (Figure 4P) but unaltered or decreased p21 levels
(Figure 4N), suggesting that the increase of p53 level in
this cell line may not cause G0/G1 cell cycle arrest. In this
context, the role of p21 is particularly complicated, as this
protein can be activated by p53-independent mechanisms
upon exposure to p-coumaric acid and NaB (Figure 4N).
4. Discussion
The principal aim of cancer chemoprevention is the use of
pharmacological or natural agents to prevent or stop the
process of tumorigenesis. Here we demonstrated that all
four phenolic compounds found in peanut testa extracts
(Khaopha et al., 2015) possess HDAC inhibitory activity
and may inhibit the growth of colon cancer cells. Among
the four phenolic compounds tested, resveratrol exhibited
the most effective HDAC inhibition (Table 1; Figure 1) and
cell growth inhibition (Table 2). An imbalance between
acetylation and deacetylation changes the structure and
the activity of histone proteins, influencing cancer cell
functions such as gene expression, cell cycle progression,
and cell death pathways (Drummond et al., 2005; Peart et al.,

2005). In addition, HDAC inhibitor-induced accumulation
of acetylated histones may affect cell cycle progression
by altering the ability of tumor cells to undergo mitosis
(Warrener et al., 2003). However, the relationship between
hyperacetylation of histone proteins and cell growth
inhibition is still unclear. Previous studies demonstrated
that combination treatments of HDAC inhibitors and the
current anticancer drug cisplatin may lead to enhanced
anticancer efficacy and reduced cytotoxicity to normal
cells (Shen et al., 2007; Ong et al., 2012; Asgar et al., 2016).
Drug combination studies between the peanut phenolicbased HDAC inhibitors and current anticancer drugs such
as cisplatin and 5-fluorouracil are of future interest with
the aim to reduce toxicity and resistance based on their
differences in drug targets. Consistent with our results,
resveratrol has been found to inhibit proliferation in a
number of cancer cell lines (Agrawal et al., 2002). Moreover,
resveratrol as well as some other phenolic compounds
of natural origin, including curcumin and capsaicin,
exhibited growth inhibition against HL-60, K-562, MCF7, and HeLa cells (Roy et al., 2002). It is noteworthy that
all four phenolic compounds in this study were less toxic
on noncancer cells than cancer cells, consistent with
many other phenolic compounds (Nakajima et al., 2009).
Similarly, the noncancer cell line appeared to be resistant
to both sodium butyrate and phenolic-rich extracts of
Hydnophytum formicarum Jack rhizome (Senawong et al.,
2013).
According to the apoptosis results, it is evident that
apoptosis induction is the underlying mechanism for
cancer cell growth inhibition by the four peanut phenolic
compounds (Figure 2). Regarding phenolic compoundinduced apoptosis, phenolic-rich extracts and sinapinic
acid from H. formicarum also inhibited the growth of HeLa
cells by induction of apoptosis (Senawong et al., 2013).
Similarly, the natural phenolic compounds curcumin,
resveratrol, and capsaicin act as chemopreventive agents
by inducing apoptosis in tumor cells (Roy et al., 2002).
Phenolic compounds from blueberries also showed
growth inhibition and apoptosis induction of colon cancer
cell lines (Yi et al., 2005). Resveratrol induced a decrease in
proliferation rates and an increase in apoptosis in prostate
cancer cell lines in a dose-dependent manner (Benitez et
al., 2007). In addition, p-coumaric and ferulic acids have
previously been reported to induce cancer cell apoptosis
(Jaganathan et al., 2013; Peng et al., 2013).
The cell cycle profiles indicate that all four phenolic
compounds inhibited cancer cell growth via induction
of not only apoptosis but also cell cycle arrest (Table 3).
Moreover, a noncancer cell line (Vero cells) was not
arrested at any particular phase of the cell cycle (data not
shown). All four phenolic compounds and NaB induced
a small increase in sub-G1 in the Vero cells. Our findings
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Figure 4. The effect of peanut phenolic compounds on the expression levels of cell cycle and apoptosis regulatory proteins. The protein
expression levels of p21, CDK4, and p53 in HT29 (A–H) and HCT116 (I–P) cells were determined after treatment with phenolic
compounds and NaB where β-actin was used as a loading control. Proteins were extracted from cell lysates, separated by SDS-PAGE,
and probed with the respective antibodies. C represents the protein level in the solvent control treatment. Quantification of the relative
expression of these proteins in HT29 (F–H) and HCT116 (N–P) cells was determined using Genetool software (Genesys).

on cell cycle arrest are in agreement with several findings
on induction of cancer cell cycle arrest by some phenolic
compounds. For example, the growth inhibitory activity
of ellagic acid was accompanied by induction of arrest of
the cell cycle in the G0/G1 phase of human bladder cancer
T24 cells (Li et al., 2005). Resveratrol was also reported to
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induce growth inhibition along with arrest in the S phase
of several human cancer cell lines (Joe et al., 2002).
Treatment of the HCT116 cells with all four phenolic
compounds resulted in ERK1/2 activations (Figures 3B,
3D, 3F, and 3H). The observed ERK1/2 activations may
be associated with oxidative stress upon drug treatment.
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Previous reports have revealed that ERK1/2 activation
induced ROS generation and endoplasmic reticulum stress
mainly via the PERK-eIF2α pathway, causing apoptosis
(Tan and Chiu, 2013). The activation of MAPKs through
intracellular ROS has been documented (Martindale
and Holbrook, 2002). Similarly, intracellular ROS lead to
activation of ERK1/2 and induce apoptosis in cancer cells
(Shin et al., 2009). The precise role of ROS in the signaling
of apoptosis is very complicated, as both the intrinsic
and extrinsic pathways are known to be associated with
ROS (Mates et al., 2008). Previous reports demonstrated
that oxidative stress induced by chemopreventive drugs
reduced mitochondrial membrane potential and caused
cytochrome c to be released from the mitochondria,
resulting in the activation of caspase-9 (Bagriacik et al.,
2007). However, our findings suggest a more complicated
role of ERK1/2 inhibition in promoting cell cycle arrest
and apoptosis upon phenolic compound treatment.
It is widely accepted that p53 expression regulates
apoptosis and/or cell cycle arrest in response to DNA
damage by anticancer agents. In accordance with previous
reports that HDAC inhibitors caused cell death in a
p53-dependent manner (Zhao et al., 2006), ferulic acid
and resveratrol could induce cell death and activate p53
expression in HCT116 cells (Figure 4P). However, both
upregulation and downregulation of p21 were observed
upon treatment of the colon cancer cells with the four
phenolic compounds (Figures 4F and 4N). This suggests
that modes of cell death other than apoptosis may operate
in tumor cells following exposure to sinapinic acid, or, more
generally, to DNA-damaging agents (te Poele et al., 2002).
Expression of p21 coincides with the hyperacetylation of
histones H3 and H4 in its promoter region (Richon et al.,
2002), indicating that HDAC enzymes negatively regulate
p21 expression in many cell types. However, in HT29 cells,
p53-independent induction of p21 expression seems to be
a prerequisite for apoptosis (Agrawal et al., 2002) and also
seems to sensitize tumor cells to the actions of different
agents. Interestingly, our observations do not comply with
either view. In fact, while the induction of p21 expression
in p53-proficient and -deficient cell lines was responsive
to drug treatment, this did not parallel the difference in
apoptotic cells between the HCT116 and HT29 cells.
Regarding CDK4, all phenolic compounds tested in this
study caused downregulation of CDK4 in the HCT116
cells (Figure 4O). As with NaB treatment (Sherr, 1994),
the decreased CDK4 level resulting from the phenolic
compound treatments may facilitate controlling the cell
cycle progression at the G1 phase in HCT116 cells.

Similar to our observation, it has been shown that
resveratrol induced the expression of p21/WAF1 and
decreased CDK4 expression in human vascular smooth
muscle cells in which p21 expression was p53-independent
(Lee and Moon, 2005). However, resveratrol induced-cell
cycle arrest was mediated by increased expression of the
modulator proteins p53 and p21 and decreased CDK4
expression in LNCaP cells (Benitez et al., 2007). Some
research findings with regard to p21 and CDK4 coincide
with our observations only for p-coumaric acid and
NaB treatments. Ellagic acid increased p53 and p21 but
decreased CDK2 gene expression, which can lead to the
G0/G1 arrest of T24 cells (Li et al., 2005). It was reported
that activation of p53/p21(WAF1/CIP1) expression played a
role in G1 arrest and apoptosis in cancer cells treated with
ellagic acid (Narayanan et al., 1999).
The four peanut phenolic compounds exhibited
antiproliferative activity against colon cancer cell lines,
which was accompanied by apoptosis with p53 either
dependently or independently. As these compounds also
exhibited HDAC inhibitory activity, one may envision
that inhibition of HDAC activity may lead to a decreased
expression of CDK4 but increased expression of p21,
which eventually could block the cell cycle progression.
An oncogenic cell signaling process involving pERK1/2
activation was also responsible for growth inhibition of
HCT116 cells. This study has shown that peanut phenolic
compounds possessing HDAC inhibitory activity could
induce apoptosis and cell cycle arrest of tumor cells,
which could have an important implication in the further
development of cancer chemopreventive agents.
In summary, a possible mechanism for the protective
effect of peanut phenolic compounds against colon cancer
relates to their antiproliferative and proapoptotic effects,
leading to downregulation of cell cycle proteins and an
increase in the apoptosis of colon cancer cells.
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